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ABSTRACT 
 
Background: Numerous case reports have shown the advantage of using bronchoalveolar lavage (BAL) in 
cytologic diagnosis of primary and secondary malignant neoplasm of the respiratory system. Aim: The aim of this 
study was to determine the usefulness of BAL in the diagnosis of malignant and non malignant lesions of the lower 
respiratory tract. Material & Method: A retrospective analysis of 13 cases of BAL fluid received at cytology 
department was analyzed for its utility in diagnosing and its usefulness for confirming the diagnosis. Result: From 
13 cases 3 cases were found to be positive for malignant cells.Male to female ratio was 4:1. Age distribution varied 
between 18years to 80 years. Conclusion: BAL proved to be a valuable diagnostic tool in detecting malignant and 
non malignant lesions. 
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Introduction 
 
Broncho alveolar lavage (BAL) was introduced into 
clinical practice in the early 1980s[1].Broncho alveolar 
lavage (BAL) is a method to recover a sample of cells 
that occupy the lining of the airways and alveoli[2] 
Cytology of BAL provides useful information on the 
status of tissues adjacent to airspaces that exude cells 
into airspaces.The use of cytological methods in the 
diagnosis of malignant lesions of the respiratory tract has 
been generally acclaimed as one of its most successful 
applications[3].Despite clear evidence that BAL 
cytology can be used to diagnose various lung diseases, 
it is under-utilized as a diagnostic tool. Analysis of BAL 
fluid can lead to the diagnosis of pulmonary infection as 
well as provide WBC differential cell counts and other 
findings that can aid in the diagnosis and management of 
a variety of lung diseases, but the results of BAL 
analysis must always be interpreted in the context of 
clinical presentation,  
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radiographic imaging studies, and other pertinent testing. 
Our aim was to study and compare the efficacy of very 
unpopular cytological technique in diagnosing carcinoma 
of lung by correlating them with histopathological 
diagnosis by bronchial biopsy.BAL cytology can be used 
as a diagnostic tool has been highlighted in our study. 
Our study includes 13 BAL samples which were 
received at cytology laboratory of Govt. Medical 
College, Surat in the year 2012. Samples were subjected 
to processing and staining. Microscopic evaluation was 
done and their conclusions were reported. 
 
Materials and methods 
 
The samples were obtained by flexible fiber-optic 
bronchoscopy done by the pulmonologist. Broncho-
alveolar lavage samples were received as 20ml aliquots 
of normal saline in sterile vials. The total fluid received 
is kept at room temperature and received in laboratory 
within 1 hr of collection because the cells are not well 
preserved in the saline solution.Once received BAL is 
assessed for its physical properties and then it is 
subjected to processing. In a centrifuge machine BAL 
fluid is centrifugedat 1500 rpm for 10 minutes and a cell 
suspension is prepared. Processing is easily and quickly 
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accomplished by streaking a cell suspension onto a 
microscope slide with the aid of a straight edge, typically 
a second microscope slide. A number of slides are 
prepared and then they are fixed in methanol by two 
techniques, i.e. dry fixation (air drying and fixation)and 
wet fixation. The air dried smears were stained with 
May-Grunwald Giemsa and the wet fixed slides with 
Papanicolaou and Hematoxylin & Eosin stains. 
To ensure that the obtained material represents the 
situation in the alveoli (BAL), a number of criteria have 
been established. A BAL fluid is regarded non-
representative if it fulfills one of the following criteria:  
i) volume< 20 ml,  
ii) total cell count < 60.000 cells/ml,  
iii) presence of > 1% squamous epithelial cells, 
 iv) presence of > 5% bronchial epithelial cells,  
v) presence of extensive amounts of debris, 
 vi) severely damaged cell morphology. 
BAL fluid, its appearance, colour, percentages of various 
cellular components can lead to diagnosis of various lung 
diseases.   
 
Results 
 
Our study includes 13 BAL samples which were 
received at cytology laboratory of Govt. Medical 
College, Surat in the year 2012. Samples were subjected 
to processing and staining. Microscopic evaluation was 
done and their conclusions were reported. Majority of 
BAL fluid samples received from various patients had 
complained of cough with expectoration. Male to female 
ratio was 4:1. Age distribution varied between 18years to 
80 years.Out of 13 BAL samples received 3 showed 
malignant lesions.All 3 samples with malignant cells on 
cytology were found to have malignant lesion on 
histopathological evaluation. 9 BAL samples on 
cytology were reported as malignant cells are not 
appreciated. Further follow up of these samples was not 
possible as patients were lost to follow up. For 1 fluid no 
conclusive opinion could be arrived was reported on 
cytological evaluation and its further follow up was also 
not possible. 
 
Discussion 
 
The diagnostic and prognostic utility of BAL was first 
evaluated in the 1980s .By definition BAL is a method 
for the recovery of cellular and non-cellular components 
from the lower respiratory tract (e.g. alveoli)[4]. It is a 
safe technique, with few major complications[5]. In 
many cases (e.g. pulmonary proteinosis, alveolar 
hemorrhage, eosinophilic pneumonia) BAL can replace 
lung biopsy[6]. Broncho-alveolar lavage (BAL), which 
was originally developed as a therapeutic tool for 
pulmonary conditions like pulmonary alveolar 
proteinosis, cystic fibrosis and intractable asthma, also 
has gained acceptance and steady popularity as a tool for 
diagnosing lung cancer[3,7].The investigatory technique 
of BAL has become one of the most valuable research 
tools for studying inflammatory mechanisms in a wide 
range of diseases that affect the lungs and airways in 
humans. In addition, cytological and microbiological 
testing of BAL samples are of established value for 
assisting in clinical diagnosis and management of many 
lung diseases, and these procedures are available 
routinely [8]. 
Bronchoalveolar lavage (BAL) represents an additional 
tool in the assessment of the health status of the lung that 
can facilitate the diagnosis of various diffuse lung 
diseases as well as malignant lesions. BAL fluid is 
competent to provide cells and solutes from the lower 
respiratory tract. BAL fluid can be analyzed to determine 
white blood cell (WBC) profiles and to detect respiratory 
pathogens. Although BAL is seldom useful as a "stand-
alone" diagnostic test for the diagnosis of diffuse 
infiltrative lung disease, when combined with clinical 
data and high-resolution computed tomography of the 
chest, BAL WBC profiles can contribute significantly to 
the diagnosis of specific forms of interstitial lung disease 
(ILD) and malignant lesions. 
The BAL procedure is practically associated with no 
mortality and carries a low complication rate of 0–
2.3%[9-11]The BAL fluid obtained from healthy, 
nonsmoking adults without lung disease contains only 
small percentages of lymphocytes, neutrophils and other 
inflammatory cells; alveolar macrophages are the 
predominant cell population (80–90%). Differential cell 
count in healthy non-smokers have been reported to 
show macrophages >80%, lymphocytes ≤15%, 
neutrophils ≤3%, eosinophils ≤0.5%, and mast cells 
≤0.5%.12 A high percentage of epithelial cells (>5%) is 
indicative of contamination of the alveolar samples by 
bronchial cells. 
Percentage of various cells can give clue to diagnosis of 
a specific disease. Apart from the cells mentioned above 
various abnormal cellular components can be present. 
Malignancy can be diagnosed on the type of cells 
present.BAL is not as sensitive for solid tumours as 
biopsy and cytology techniques. Diffuse malignant 
infiltrates can be reliably diagnosed in 60–90% of cases. 
The highest yield is seen in widespread malignancies, 
such as primary bronchoalveolar carcinoma or 
lymphangitic carcinomatosis due to adenocarcinoma. It 
can also provide diagnostic cytological material in 
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haematological malignancies of the lung, including 
Hodgkin’s disease, non-Hodgkin lymphoma, leukaemia, 
Waldenstrom’s macroglobulinaemia, myeloma and mycosis 
fungoides.[13,14]BAL has achieved the greatest diagnostic 
value among immunocompromised patients with pulmonary 
infiltrates. The sensitivity of BAL ranges from 60–90% in 
the diagnosis of bacterial infections, 70–80% in 
mycobacterial, fungal and mostviral infections, and from 
90– 95% in Pneumocystis carinii pneumonia. The 
characteristic cysts of Pneumocystis can be detected on 
May-Grunwald-Giemsa stained slides. In cytomegalovirus 
pneumonia, the characteristic cytomegalic-transformed cell 
(the owl eye cell) with typical nuclear or cytoplasmic 
inclusions is highly specific and can be seen on light 
microscopy in 30–50% of cases. CT scan was done in only 
2 patients of all the samples received.BAL Cytology can be 
useful to diagnose malignant lesions of lung and can give 
conclusion with certainty that the lesion is not malignant 
which has been highlighted in our study. 
 
Conclusion 
 
Bronchoalveolar lavage is an easily performed and well 
tolerated procedure able to provide cellular contents, 
cellular products, and proteins from the lower respiratory 
tract. In the rapidly evolving field of pulmonary diagnostic 
tests, If BAL is properly performed and analyzed, 
characterization of BAL fluid specimens with the 
determination of nucleated immune cell patterns, BAL has a 
specific value for the diagnosis of certain ILD’s, such as 
alveolar proteinosis, Pneumocystis pneumonia, 
bronchoalveolar carcinoma, malignant non-Hodgkin 
lymphoma and alveolar haemorrhage, allowing surgical 
lung biopsy to be avoided. Although it provides good 
diagnostic efficacy, it is under utilized as a diagnostic tool. 
Before any surgical interventions are undertaken a 
cytological evaluation of BAL fluid should always be 
considered. This method is also valid support for research. 
Genetic and molecular biomarkers, with different 
diagnostic/prognostic significance, can be detected in BAL. 
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